These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 21929528

  • 1. Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study.
    Joyeux-Faure M, Durand M, Bedague D, Protar D, Incagnoli P, Paris A, Ribuot C, Levy P, Chavanon O.
    Fundam Clin Pharmacol; 2012 Dec; 26(6):761-70. PubMed ID: 21929528
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?
    Karuppasamy P, Chaubey S, Dew T, Musto R, Sherwood R, Desai J, John L, Shah AM, Marber MS, Kunst G.
    Basic Res Cardiol; 2011 Jun; 106(4):511-9. PubMed ID: 21544683
    [Abstract] [Full Text] [Related]

  • 7. [Effect of hydroxyethyl starch 130/0.4 on S100B protein level and cerebral oxygen metabolism in open cardiac surgery under cardiopulmonary bypass].
    Pi ZB, Tan GX, Wang JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 17; 87(27):1908-11. PubMed ID: 17923015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning).
    Wang X, Wei M, Kuukasjärvi P, Laurikka J, Rinne T, Moilanen E, Tarkka M.
    Scand Cardiovasc J; 2009 Feb 17; 43(1):72-9. PubMed ID: 18609065
    [Abstract] [Full Text] [Related]

  • 10. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery.
    Popov AF, Schulz EG, Schmitto JD, Coskun KO, Tzvetkov MV, Kazmaier S, Zimmermann J, Schöndube FA, Quintel M, Hinz J.
    Artif Organs; 2010 Nov 17; 34(11):961-8. PubMed ID: 21092038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A, Sujatha DI, Kanagarajan N, Vijayalakshmi MA, Ninan B.
    Ann Vasc Surg; 2009 Nov 17; 23(5):645-51. PubMed ID: 19467834
    [Abstract] [Full Text] [Related]

  • 14. A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass.
    Bennett-Guerrero E, Swaminathan M, Grigore AM, Roach GW, Aberle LG, Johnston JM, Fink MP.
    J Cardiothorac Vasc Anesth; 2009 Jun 17; 23(3):324-9. PubMed ID: 18835526
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.
    Lazar HL, Bokesch PM, van Lenta F, Fitzgerald C, Emmett C, Marsh HC, Ryan U, OBE and the TP10 Cardiac Surgery Study Group.
    Circulation; 2004 Sep 14; 110(11 Suppl 1):II274-9. PubMed ID: 15364875
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.